AnaptysBio Cash from Financing (TTM) Insights

AnaptysBio Inc (ANAB)

25.77 -0.81 (-3.05%) USD | NASDAQ | May 06, 16:00

25.77 0.00 (0.00%) After-Hours: 20:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2015. Upgrade now.

Date	Value
December 31, 2023	-59.30M
September 30, 2023	-52.19M
June 30, 2023	-12.09M
March 31, 2023	1.834M
December 31, 2022	44.02M
September 30, 2022	293.40M
June 30, 2022	256.62M
March 31, 2022	256.74M
December 31, 2021	252.30M
September 30, 2021	1.088M
June 30, 2021	1.11M
March 31, 2021	0.627M
December 31, 2020	-0.879M
September 30, 2020	-1.116M
June 30, 2020	-2.80M
March 31, 2020	-4.531M
December 31, 2019	-4.493M

Date	Value
September 30, 2019	-5.754M
June 30, 2019	222.26M
March 31, 2019	223.45M
December 31, 2018	223.36M
September 30, 2018	437.12M
June 30, 2018	210.83M
March 31, 2018	210.37M
December 31, 2017	292.45M
September 30, 2017	89.74M
June 30, 2017	89.06M
March 31, 2017	89.61M
December 31, 2016	8.628M
September 30, 2016	-1.933M
June 30, 2016	38.71M
March 31, 2016	39.08M
December 31, 2015	39.40M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

-59.30M

Minimum

Dec 2023

293.40M

Maximum

Sep 2022

62.47M

Average

0.627M

Median

Mar 2021

Cash from Financing (TTM) Benchmarks